The well-known investment firm Royalty Pharma has just announced its intention of buying royalties on Vertex Pharmaceuticals Inc.’s cystic fibrosis drug, Kalydeco. Kalydeco received its Food and Drug Administration approval in January 2012 after being co-developed with the help of the Cystic Fibrosis Foundation. This deal is planned to fund further therapies for the disease, Royal Pharma … [Read more...]
You are here: Home / Archives for royalties bought from vertex pharma